Diabetes Research and Clinical Practice
Volume 76, Issue 2 , Pages 187-192 , May 2007

Taurine in women with a history of gestational diabetes

  • Giuseppe Seghieri

      Affiliations

    • Department of Internal Medicine, Spedali Riuniti, Viale Matteotti 19, 51100 Pistoia, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 0573352325; fax: +39 0573352005.
    • ,
  • Federica Tesi

      Affiliations

    • Department of Internal Medicine, Spedali Riuniti, Viale Matteotti 19, 51100 Pistoia, Italy
    • ,
  • Loria Bianchi

      Affiliations

    • Department of Internal Medicine, Spedali Riuniti, Viale Matteotti 19, 51100 Pistoia, Italy
    • ,
  • Alberto Loizzo

      Affiliations

    • Istituto Superiore di Sanità, Roma, Italy
    • ,
  • Giuseppe Saccomanni

      Affiliations

    • Department of Pharmaceutical Sciences, University of Pisa, Italy
    • ,
  • Giovanni Ghirlanda

      Affiliations

    • Department of Internal and Geriatric Medicine, Catholic University, Roma, Italy
    • ,
  • Roberto Anichini

      Affiliations

    • Department of Internal Medicine, Spedali Riuniti, Viale Matteotti 19, 51100 Pistoia, Italy
    • ,
  • Flavia Franconi

      Affiliations

    • Center for Biotechnology Development and Biodiversity Research and Department of Pharmacology, University of Sassari, Italy

Received 16 August 2006 ,Accepted 21 August 2006.

References 

  1. Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EAH. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am. J. Obstet. Gynecol. 1991;165:1667–1672
  2. Moses GR. The recurrence rate of gestational diabetes in subsequent pregnancies. Diabet. Care. 1996;19:1348–1350
  3. Peters RK, Kjos SL, Xiang A, Buchanan TA. Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet. 1996;347:227–230
  4. Catalano PM, Tyzbir ED, Wolfe RR, Calles J, Roman NM, Amini SB, et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. Am. J. Physiol. 1993;264:E60–E67
  5. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes. Am. J. Obstet. Gynecol. 1999;180:903–916
  6. Ryan EA, Imes S, Liu D, McManus R, Finegood DT, Polonsky KS, et al. Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes. 1995;44:506–512
  7. Kautzky-Willer , Prager R, Waldhausl W, Pacini G, Thomaseth K, Wagner OF, et al. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabet. Care. 1997;20:1717–1723
  8. Osei K, Gaillard TR, Schuster DP. History of gestational diabetes leads to distinct metabolic alterations in nondiabetic African–American women with a parental history of type 2 diabetes. Diabet. Care. 1998;21:1250–1257
  9. Homko C, Sivan E, Chen X, Reece EA, Boden G. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 2001;86:568–573
  10. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes. Diabet. Care. 2002;25:1862–1868
  11. Kautzky-Willer , Pacini G, Tura A, Bieglmayer C, Schneider B, Ludvik B, et al. Increased plasma leptin in gestational diabetes. Diabetologia. 2001;44:164–172
  12. Winkler G, Cseh K, Baranyi E, Melczer Z, Speer G, Hajos P, et al. Tumor necrosis factor system and insulin resistance in gestational diabetes. Diabet. Res. Clin. Pract. 2002;56:93–99
  13. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J. Clin. Endocrinol. Metab. 2003;88:3507–3512
  14. Retnakaran R, Hanley AJ, Raif N, Hirning CR, Connelly PW, Sermer M, et al. Adiponectin and beta cell dysfunction in gestational diabetes patho-physiological implications. Diabetologia. 2005;48:993–1001
  15. Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 2004;89:2306–2311
  16. Hansen SH. The role of taurine in diabetes mellitus and development of diabetic complications. Diabet. Metab. Res. Rev. 2001;17:330–346
  17. Franconi F, Di Leo MAS, Bennardini F, Ghirlanda G. Is taurine beneficial in reducing risk factors for diabetes mellitus?. Neurochem. Res. 2004;29:143–150
  18. Franconi F, Loizzo A, Ghirlanda G, Seghieri G. Taurine supplementation in diabetes mellitus. Curr. Opin. Clin. Nutr. Metab. Care. 2006;9:32–36
  19. Aerts L, Van Assche FA. Taurine and taurine-deficiency in the perinatal period. J. Perinatal. Med. 2002;30:281–286
  20. Dahri S, Snoeck A, Reusens-Billen B, Remacle C, Hoet JJ. Islet function in offspring of mothers on low-protein diet during gestation. Diabetes. 1991;40(Suppl. 2):115–120
  21. Cherif H, Reusens B, Ahn MT, Hoet JJ, Remacle C. Effects of taurine on the insulin secretion of rat fetal islets from dams fed a low-protein diet. J. Endocrinol. 1998;159:341–348
  22. Franconi F, Bennardini F, Mattana A, Miceli M, Ciuti M, Mian M, et al. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am. J. Clin. Nutr. 1995;61:1115–1119
  23. De Luca G, Calpona PR, Caponetti A, Romano G, Di Benedetto A, Cucinotta D, et al. Taurine and osmoregulation: platelet taurine content, uptake, and release in type 2 diabetes mellitus. Metabolism. 2001;50:60–64
  24. Wijekoon EP, Skinner C, Brosnan ME, Brosnan JT. Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. Can. J. Physiol. Pharmacol. 2004;82:506–514
  25. Williams RE, Lenz EM, Evans JA, Wilson ID, Granger JH, Plumb RS, et al. A combined 1H NMR and HPLC-MS-based metabonomic study of urine from obese [fa/fa] Zucker and normal Wistar-derived rats. J. Pharmaceut. Biomed. Anal. 2005;3:465–471
  26. Weijers RN, Bekedam DJ, Smulders YM. Determinants of mild gestational hyperglycemia and gestational diabetes mellitus in a large Dutch multiethnic cohort. Diabet. Care. 2002;25:72–77
  27. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabet. Care. 1999;22:462–1470
  28. Kirwan JP, Huston-Presley H, Kalhan SC, Catalano PM. Clinically useful estimates of insulin sensitivity during pregnancy. Diabet. Care. 2001;24:1602–1607
  29. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am. J. Obstet. Gynecol. 1982;144:768–773
  30. Andereson MEJ, Lean G, Vespasiani M, Bruni V. Development of a barcode system for nutrient analysis in the UK. AS Diabetologia. 1992;35(Suppl. 1):A165
  31. Franconi F, Bennardini F, Mattana A, Miceli M, Ciuti M, Mian M, et al. Taurine levels in plasma and platelets in insulin-dependent and non-insulin dependent diabetes mellitus: correlation with platelet aggregation. In:  Huxtable R,  Michalk DV editor. Taurine in Health and Disease. New York, NY: Plenum Press; 1994;p. 419–424
  32. Huxtable RJ. Physiological actions of taurine. Physiol. Rev. 1992;72:101–163
  33. Stipanuk MH. Role of liver in the regulation of body cysteine and taurine levels: a brief review. Neurochem. Res. 2004;29:105–110
  34. Schuller-Levis G, Park E. Taurine: new applications for an old amino acid. FEMS Microbiol. Lett. 2003;226:195–202
  35. Cetin , Nobile de Santis MS, Taricco E, Radaelli T, Teng C, Ronzoni S, et al. Maternal and fetal amino acid concentrations in normal pregnancies and in pregnancies with gestational diabetes mellitus. Am. J. Obstet. Gynecol. 2005;192:610–617
  36. Lim JG, Lee HY, Yun JE, Kim SP, Park JW, Suh SI, et al. Taurine block of cloned ATP-sensitive K+ channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes. Biochem. Pharmacol. 2004;68:901–910
  37. Han J, Bae JH, Kim SY, Lee HY, Jang BC, Lee IK, et al. Taurine increases glucose sensitivity of UCP2-overexpressing beta-cells by ameliorating mitochondrial metabolism. Am. J. Physiol. Endocrinol. Metab. 2004;287:E1008–E1018
  38. Arany E, Strutt B, Romanus P, Remacle C, Reusens B, Hill DJ. Taurine supplement in early life altered islet morphology, decreased insulitis and delayed the onset of diabetes in non-obese diabetic mice. Diabetologia. 2004;47:1831–1837
  39. Chang KJ, Kwon W. Immunohistochemical localization of insulin in pancreatic beta-cells of taurine-supplemented or taurine-depleted diabetic rats. Adv. Exp. Med. Biol. 2000;483:579–587
  40. Brons C, Spohr C, Storgaard H, Dyerberg J, Vaag A. Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus. Eur. J. Clin. Nutr. 2004;58:1239–1247

PII: S0168-8227(06)00372-X

doi: 10.1016/j.diabres.2006.08.008

Diabetes Research and Clinical Practice
Volume 76, Issue 2 , Pages 187-192 , May 2007

Article Tools